DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
DISTIGMINE BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DISTIGMINE BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
750F36OP6J
Molecule Type:
Small molecule
Molecular Formula:
C22H32Br2N4O4
Molecular Weight:
576.33
AlogP:
2.46
PSA:
66.84
HBD:
0.0
HBA:
#RotB:
9.0
Source:
BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM
4
Combination
Approved
Unknown
OPHTHALMIC
Unknown
Unknown
BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FORMOTEROL FUMARATE; MOMETASONE FUROATE
4
Combination
Approved
OTHER; PEDIATRICS; RESPIRATORY
INHALATION
Unknown
Unknown
FORMOTEROL FUMARATE; MOMETASONE FUROATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEXENONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MEXENONE
×
Maximum Phase:
4
First Approval:
None
UNII:
ET1UGF4A0B
Molecule Type:
Small molecule
Molecular Formula:
C15H14O3
Molecular Weight:
242.27
AlogP:
2.94
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BETADINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BETADINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MENTHOL; METHYL SALICYLATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
MENTHOL; METHYL SALICYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; TELMISARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; TELMISARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM DOBESILATE
4
Small molecule
Approved
Unknown
Unknown
Rosacea; Diabetes Mellitus, Type 2; Infertility; Menorrhagia; Varicose Veins
Unknown
CALCIUM DOBESILATE
×
Maximum Phase:
4
First Approval:
None
UNII:
5921X1560Q
Molecule Type:
Small molecule
Molecular Formula:
C12H10CaO10S2
Molecular Weight:
418.41
AlogP:
0.34
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
1.0
Source:
NALBUPHINE SEBACATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
NALBUPHINE SEBACATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PERAZINE
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Psychotic Disorders; Schizophrenia
Unknown
PERAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8915147A2B
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3S
Molecular Weight:
339.51
AlogP:
3.93
PSA:
9.72
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MISTLETOE EXTRACT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MISTLETOE EXTRACT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN GLARGINE-YFGN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN GLARGINE-YFGN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IL-2
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IL-2
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDALPINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Serotonin transporter inhibitor
INDALPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
V35562QSVT
Molecule Type:
Small molecule
Molecular Formula:
C15H20N2
Molecular Weight:
228.34
AlogP:
3.1
PSA:
27.82
HBD:
2.0
HBA:
#RotB:
3.0
Source:
XENAZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
XENAZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
KDU8VH09O8
Molecule Type:
Small molecule
Molecular Formula:
C23H21NO4
Molecular Weight:
375.42
AlogP:
4.71
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
8.0
Source:
CHLOROQUINE SULPHATE
4
Small molecule
Approved
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
CHLOROQUINE SULPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
OE48649K6N
Molecule Type:
Small molecule
Molecular Formula:
C18H28ClN3O4S
Molecular Weight:
417.96
AlogP:
4.81
PSA:
28.16
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DEXFENFLURAMINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Serotonin (5-HT) receptor agonist
DEXFENFLURAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
PM28L0FHNP
Molecule Type:
Small molecule
Molecular Formula:
C12H17ClF3N
Molecular Weight:
267.72
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLYNOXYLIN
4
Small molecule
Approved
Unknown
Unknown
Infections
Unknown
POLYNOXYLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
E18NBG5EEY
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HMB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HMB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC; TOPICAL
Unknown
Unknown
HYDROCORTISONE ACETATE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLATROPINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
METHYLATROPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
80719I460H
Molecule Type:
Small molecule
Molecular Formula:
C18H26NO3+
Molecular Weight:
304.41
AlogP:
2.08
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ADAPALENE; BENZOYL PEROXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
ADAPALENE; BENZOYL PEROXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MPA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MPA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M POLYPHOSPHATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M POLYPHOSPHATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CILNIDIPINE
4
Small molecule
Approved
Unknown
Unknown
Polycystic Kidney, Autosomal Dominant; Cardiovascular Diseases; Hypertension
Voltage-gated L-type calcium channel blocker
CILNIDIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
S85436ZG85
Molecule Type:
Small molecule
Molecular Formula:
C27H28N2O7
Molecular Weight:
492.53
AlogP:
4.28
PSA:
117.0
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ARSENIC
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ARSENIC
×
Maximum Phase:
4
First Approval:
None
UNII:
V1I29R0RJQ
Molecule Type:
Small molecule
Molecular Formula:
H3As
Molecular Weight:
77.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TINEFCON
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TINEFCON
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLATUZUMAB VEDOTIN-PIIQ
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
POLATUZUMAB VEDOTIN-PIIQ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; VALSARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; VALSARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
273
274
275
276
277
278
279
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA